1. Home
  2. ACET vs ESP Comparison

ACET vs ESP Comparison

Compare ACET & ESP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACET
  • ESP
  • Stock Information
  • Founded
  • ACET 1947
  • ESP 1928
  • Country
  • ACET United States
  • ESP United States
  • Employees
  • ACET N/A
  • ESP N/A
  • Industry
  • ACET Biotechnology: Pharmaceutical Preparations
  • ESP Industrial Machinery/Components
  • Sector
  • ACET Health Care
  • ESP Technology
  • Exchange
  • ACET Nasdaq
  • ESP Nasdaq
  • Market Cap
  • ACET 83.2M
  • ESP 84.1M
  • IPO Year
  • ACET N/A
  • ESP N/A
  • Fundamental
  • Price
  • ACET $0.98
  • ESP $27.92
  • Analyst Decision
  • ACET Buy
  • ESP
  • Analyst Count
  • ACET 5
  • ESP 0
  • Target Price
  • ACET $5.67
  • ESP N/A
  • AVG Volume (30 Days)
  • ACET 1.6M
  • ESP 13.7K
  • Earning Date
  • ACET 03-18-2025
  • ESP 02-12-2025
  • Dividend Yield
  • ACET N/A
  • ESP 3.11%
  • EPS Growth
  • ACET N/A
  • ESP 31.14
  • EPS
  • ACET N/A
  • ESP 2.45
  • Revenue
  • ACET N/A
  • ESP $43,917,522.00
  • Revenue This Year
  • ACET N/A
  • ESP N/A
  • Revenue Next Year
  • ACET N/A
  • ESP N/A
  • P/E Ratio
  • ACET N/A
  • ESP $11.48
  • Revenue Growth
  • ACET N/A
  • ESP 18.62
  • 52 Week Low
  • ACET $0.81
  • ESP $20.20
  • 52 Week High
  • ACET $2.61
  • ESP $33.00
  • Technical
  • Relative Strength Index (RSI)
  • ACET 57.01
  • ESP 51.06
  • Support Level
  • ACET $0.84
  • ESP $25.40
  • Resistance Level
  • ACET $1.04
  • ESP $28.64
  • Average True Range (ATR)
  • ACET 0.08
  • ESP 0.99
  • MACD
  • ACET 0.01
  • ESP 0.07
  • Stochastic Oscillator
  • ACET 68.65
  • ESP 73.72

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its lead product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its lead preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

About ESP Espey Mfg. & Electronics Corp.

Espey Manufacturing & Electronics Corp designs, develops, tests, and manufactures specialized military and rugged industrial power supplies and transformers for use in harsh or severe environment applications. Its products and solutions include power converters, power conditioning, high-voltage radar, contract manufacturing, custom engineering, and others. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power.

Share on Social Networks: